Trade Mark Journal No.2026/042 16 October 2026

UK00004453999 1 October 2026 (5,40,42,44)

Mark 1

Image for mark UK00004453999_1of3 QuellTX

Mark 2

Image for mark UK00004453999_2of3

Mark 3

Image for mark UK00004453999_3of3
Class 5
Pharmaceutical and biological preparations for diagnostic, medical, therapeutic and prophylactic use; pharmaceutical, medical and veterinary preparations for diagnostic, therapeutic and prophylactic purposes; preparations for cell therapy; preparations for gene therapy; pharmaceutical, medical and clinical preparations for use in treatment, amelioration or prophylaxis of diseases, disorders or suppression of the immune system; immunological agents and preparations for medical purposes; preparations for therapies to modulate the immune system; preparations for therapies for autoimmune conditions or immunological disorders; chimeric antigen receptors and therapeutic preparations thereof; antibodies; preparations for therapeutic delivery of nucleic acids; viral or nucleic acid vectors for therapeutic or prophylactic purposes; medical preparations containing viral or nucleic acid vectors; preparations for genetically modifying human or animal cells for diagnostic and medical purposes; preparations of blood or cells extracted from humans or animals which have been adapted for therapeutic purposes.
Class 40
Pharmaceutical manufacturing and processing; biological, biotechnological or biopharmaceutical manufacturing and processing; biological tissue, blood, cell and genetic material processing; viral vector production and manufacture; gene therapy production and manufacture; custom manufacture of pharmaceutical and biological formulations or products.
Class 42
Scientific and technological services and research and design relating thereto; industrial analysis and research services; medical and veterinary research services including the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in the development of new therapies in the fields of autoimmune and immunological disorders, and to modulate the immune system; scientific research in the fields of human and animal cell therapy; scientific research in the fields of human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services.
Class 44
Medical services; medical services in the field of immunology; medical services in the field of surgery; medical services in the field of autoimmune diseases and conditions; transplants; collection and preservation of biological tissue, blood, cells and genetic materials; medical diagnostic services; medical treatment services; providing information and data for diagnosis and medical treatment; gene and nucleic acid delivery or modification for therapeutic purposes; gene therapy design and delivery; advisory services relating to gene therapy.

Quell Therapeutics Limited

Representative: Dehns